Breaking News

Close

Fate Therapeutics Inc (FATE)

Add to/Remove from Watchlist Add to Watchlist

3.870 -0.430 -10.00%

25/04 - Closed. Currency in USD ( Disclaimer )

After Hours

3.840

-0.030

-0.775%

19:59:48 - Real-time Data

Type: Equity

Market: United States

Volume: 3,601,468
Bid/Ask: 3.800 / 3.920
Day's Range: 3.780 - 4.150

Fate Therapeutics Inc Company Profile

Get an in-depth profile of Fate Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

551

Equity Type

ORD

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company’s chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Its CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Contact Information

Address 12278 Scripps Summit Drive
San Diego, 92131
United States

Phone 858 875 1800

Fax -

Web www.fatetherapeutics.com

Top Executives

Name	Age	Since	Title
J. Scott Wolchko	52	2013	Founder, CEO, President & Director
John D. Mendlein	62	2007	Independent Vice Chairman of the Board
William H. Rastetter	74	2011	Independent Chairman
Robert S. Epstein	67	2014	Independent Director
Timothy P. Coughlin	55	2013	Independent Director
Robert M. Hershberg	60	2020	Independent Director
Shefali Agarwal	48	2019	Independent Director
Yuan Xu	53	2021	Independent Director
Sean J. Morrison	-	2010	Member of Scientific Advisory Board
Lynn Megeney	-	2010	Member of Scientific Advisory Board
Robert S. Langer	74	-	Member of Scientific Advisory Board
Sui Huang	-	2010	Member of Scientific Advisory Board
Stuart Orkin	-	2010	Member of Scientific Advisory Board
Bennett M. Shapiro	83	-	Member of Scientific Advisory Board
Mark Krasnow	-	2010	Member of Scientific Advisory Board
Karin Jooss	58	2019	Independent Director
Alberto Hayek	-	2010	Member of Scientific Advisory Board
Steven L. Goldstein	-	2010	Member of Scientific Advisory Board
Michael Stewart Lee	44	2018	Independent Director

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

FATE Comments

Write your thoughts about Fate Therapeutics Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Charles Jeong Sep 11, 2023 9:48AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Fate Therapeutics, Inc. (NASDAQ:FATE) Shares Purchased by Bruce & Co. Inc.

0 0

Charles Jeong Sep 11, 2023 9:48AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Bruce & Co. Inc. Increases Stake in Fate Therapeutics, Highlighting Potential Investment Opportunity

0 0

Charles Jeong Sep 07, 2023 9:42AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Short squeeze again soon...

0 0

Charles Jeong Sep 06, 2023 10:24AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Citigroup Inc. Increases Holdings in Fate Therapeutics as Biopharmaceutical Company Exceeds EPS Expectations

0 0

Charles Jeong Sep 01, 2023 6:26AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Fate Therapeutics, Inc. (NASDAQ:FATE) Shares Bought by Citigroup Inc., The institutional investor owned 1,124,908 shares of the biopharmaceutical company's stock after purchasing an additional 929,215 shares during the quarter. Citigroup Inc. owned 1.14% of Fate Therapeutics worth $6,412,000 at the end of the most recent quarter.

0 0

Charles Jeong Sep 01, 2023 6:23AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Russell Investments Group Ltd. Acquires 171,561 Shares of Fate Therapeutics, Inc. (NASDAQ:FATE)

0 0

Charles Jeong Aug 31, 2023 10:31AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Short squeeze soon... As 8/15/2023 28,290,000 short shares $82.89 million 30.5% of outstanidng shares

0 0

Charles Jeong Aug 22, 2023 6:46PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

5 Best High Short Interest Stocks To Buy Now ; Fate Therapeutics, Inc. (NASDAQ:FATE)https://www.insidermonkey.com/blog/5-best-high-short-interest-stocks-to-buy-now-3-1186335/

0 0

Charles Jeong Aug 21, 2023 4:08PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Currently, Total Shares sold short(Short Sale) is over 30% of company's outstanding shares. It seems like it's time for a short squeeze soon.

0 0

Charles Jeong Aug 21, 2023 8:57AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Mirae Asset Global Investments Co. Ltd. Acquires 25,198 Shares of Fate Therapeutics, Inc. (NASDAQ:FATE)

0 0

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="211891591">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="211891591" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="211891591" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="211891591">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	38,165.0	+79.2	+0.21%
	US 500	5,085.8	+37.4	+0.74%
	Dow Jones	38,085.80	-375.12	-0.98%
	S&P 500	5,048.42	-23.21	-0.46%
	Nasdaq	15,611.76	-100.99	-0.64%
	S&P 500 VIX	15.58	+0.21	+1.37%
	Dollar Index	105.415	-0.036	-0.03%

	Crude Oil WTI	83.71	+0.14	+0.17%
	Brent Oil	89.10	+0.09	+0.10%
	Natural Gas	1.973	-0.013	-0.65%
	Gold	2,359.35	+16.85	+0.72%
	Silver	27.657	+0.304	+1.11%
	Copper	4.5780	+0.0605	+1.34%
	US Soybeans	1,158.25	-3.75	-0.32%

	U.S. 10Y	4.687	-0.021	-0.45%
	U.S. 30Y	4.791	-0.029	-0.60%
	U.S. 5Y	4.703	-0.014	-0.30%
	U.S. 3M	5.500	+0.096	+1.78%
	US 10Y T-Note	107.48	+0.12	+0.12%
	Euro Bund	129.99	+0.29	+0.22%
	10-2 Yield Spread	-29.77	-1.26	4.42%

	Apple	169.89	+0.87	+0.51%
	Alphabet A	156.00	-3.13	-1.97%
	Tesla	170.18	+8.05	+4.97%
	Amazon.com	173.67	-2.92	-1.65%
	Netflix	564.80	+9.68	+1.74%
	Meta Platforms	441.38	-52.12	-10.56%
	Bank of America	37.91	-0.41	-1.07%

Recent Quotes

	Name	Price	Chg.	Chg. %
	FATE	3.870	-0.430	-10.00%

	Name	Last	Chg. %	Vol.
	TSLA	170.18	+4.97%	123.18M
	META	441.38	-10.56%	81.83M
	AAPL	169.89	+0.51%	47.93M
	AMZN	173.67	-1.65%	43.43M
	NVDA	826.32	+3.71%	40.15M
	MSFT	399.04	-2.45%	34.49M
	BRKa	611,740	-0.27%	12.48K

	Name	Last	Chg. %	Vol.
	NEM	43.41	+12.46%	36.00M
	TYL	458.45	+9.42%	501.35K
	CARR	59.81	+9.20%	9.94M
	TER	108.91	+8.15%	7.83M
	CMG	3,116.02	+6.47%	641.35K
	URI	690.92	+5.45%	1.02M
	ZBRA	292.53	+5.40%	658.63K

	Name	Last	Chg. %	Vol.
	META	441.38	-10.56%	81.83M
	TXT	84.92	-9.67%	5.13M
	BMY	44.68	-8.56%	44.90M
	IBM	169.30	-8.04%	16.60M
	LUV	27.25	-6.98%	36.89M
	CAT	338.24	-6.95%	6.37M
	CMCSA	37.87	-5.82%	36.78M